N. Brook and M. Nicholson, Kidney transplantation from non heart-beating donors, The Surgeon, vol.1, issue.6, pp.311-333, 2003.
DOI : 10.1016/S1479-666X(03)80065-3

C. Troppmann, K. Gillingham, and E. Benedetti, DELAYED GRAFT FUNCTION, ACUTE REJECTION, AND OUTCOME AFTER CADAVER RENAL TRANSPLANTATION, Transplantation, vol.59, issue.7, pp.962-970, 1995.
DOI : 10.1097/00007890-199504150-00007

J. Seal and B. Gewertz, Vascular Dysfunction in Ischemia-Reperfusion Injury, Annals of Vascular Surgery, vol.19, issue.4, pp.572-84, 2005.
DOI : 10.1007/s10016-005-4616-7

H. Ushigome, H. Sano, and M. Okamoto, The Role of Tissue Factor in Renal Ischemic Reperfusion Injury of the Rat, Journal of Surgical Research, vol.102, issue.2, pp.102-111, 2002.
DOI : 10.1006/jsre.2001.6275

W. Wang, X. Fang, L. Stephenson, K. Khiabani, and W. Zamboni, Ischemia/reperfusion-induced necrosis and apoptosis in the cells isolated from rat skeletal muscle, Journal of Orthopaedic Research, vol.31, issue.3, pp.351-357, 2008.
DOI : 10.1002/jor.20493

H. Eltzschig and T. Eckle, Ischemia and reperfusion???from mechanism to translation, Nature Medicine, vol.65, issue.11, pp.1391-401, 2011.
DOI : 10.1038/nrd2425

R. Chambers and G. Laurent, Coagulation cascade proteases and tissue fibrosis, Biochemical Society Transactions, vol.30, issue.2, pp.194-200, 2002.
DOI : 10.1042/bst0300194

J. Sevastos, S. Kennedy, and D. Davis, Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury, Blood, vol.109, issue.2, pp.577-83, 2007.
DOI : 10.1182/blood-2006-03-008870

N. Yoshida, T. Takagi, Y. Isozaki, T. Suzuki, H. Ichikawa et al., Proinflammatory role of protease-activated recep- tor-2 in intestinal ischemia/reperfusion injury in rats, Mol Med Rep, vol.4, pp.81-87, 2011.

K. Borensztajn, M. Peppelenbosch, and C. Spek, Factor Xa: at the crossroads between coagulation and signaling in physiology and disease, Trends in Molecular Medicine, vol.14, issue.10, pp.429-469, 2008.
DOI : 10.1016/j.molmed.2008.08.001

C. Scotton, M. Krupiczojc, and M. K?-onigshoff, Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury, Journal of Clinical Investigation, vol.119, pp.2550-63, 2009.
DOI : 10.1172/JCI33288DS1

S. Giraud, R. Thuillier, and A. Belliard, Direct Thrombin Inhibitor Prevents Delayed Graft Function in a Porcine Model of Renal Transplantation, Transplantation, vol.87, issue.11, pp.1636-1680, 2009.
DOI : 10.1097/TP.0b013e3181a5b154

F. Favreau, R. Thuillier, and J. Cau, Anti-thrombin Therapy During Warm Ischemia and Cold Preservation Prevents Chronic Kidney Graft Fibrosis in a DCD Model, American Journal of Transplantation, vol.129, issue.Suppl, pp.30-39, 2010.
DOI : 10.1111/j.1600-6143.2009.02924.x

S. Tillet, S. Giraud, and P. Delpech, Kidney graft outcome using an anti-Xa therapeutic strategy in an experimental model of severe ischaemia-reperfusion injury, British Journal of Surgery, vol.58, issue.1, pp.132-174, 2015.
DOI : 10.1002/bjs.9662

R. Frank, G. Schabbauer, and T. Holscher, The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia-reperfusion injury, Journal of Thrombosis and Haemostasis, vol.38, issue.3, pp.531-571, 2005.
DOI : 10.1073/pnas.141126698

S. Alban, Adverse Effects of Heparin, Handb Exp Pharmacol, vol.207, pp.211-63, 2012.
DOI : 10.1007/978-3-642-23056-1_10

S. Olson, R. Swanson, and M. Petitou, Specificity and selectivity profile of EP217609: a new neutralizable dual-action anticoagulant that targets thrombin and factor Xa, Blood, vol.119, issue.10, pp.2187-95, 2012.
DOI : 10.1182/blood-2011-09-381764

M. Petitou, V. Nancy-portebois, and G. Dubreucq, From heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile, Thrombosis and Haemostasis, vol.102, pp.804-814, 2009.
DOI : 10.1160/TH09-01-0063

A. Kaeberich, U. Raaz, and A. Vogt, In vitro comparison of the novel, dual-acting FIIa/FXa-inhibitor EP217609C101, unfractionated heparin, enoxaparin, and fondaparinux in preventing cardiac catheter thrombosis, Journal of Thrombosis and Thrombolysis, vol.14, issue.1, pp.118-148, 2014.
DOI : 10.1007/s11239-013-0938-4

G. Alame, P. Mangin, and M. Freund, EP217609, a neutralisable dual-action FIIa/FXa anticoagulant, with antithrombotic effects in arterial thrombosis, Thrombosis and Haemostasis, vol.113, issue.2, pp.385-95, 2015.
DOI : 10.1160/TH14-05-0399

S. Giraud, F. Favreau, N. Chatauret, R. Thuillier, S. Maiga et al., Contribution of Large Pig for Renal Ischemia-Reperfusion and Transplantation Studies: The Preclinical Model, Journal of Biomedicine and Biotechnology, vol.8, issue.19, p.532127, 2011.
DOI : 10.1152/ajpheart.01100.2009

T. Hauet, J. Goujon, and A. Vandewalle, Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys, J Am Soc Nephrol, vol.11, pp.138-186, 2000.

K. Johnson, Y. Choi, E. Degroot, I. Samuels, A. Creasey et al., Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation, J Immunol, vol.160, pp.5130-5135, 1998.

G. Demetz and I. Ott, The Interface between Inflammation and Coagulation in Cardiovascular Disease, International Journal of Inflammation, vol.100, issue.15, p.860301, 2012.
DOI : 10.1016/S0002-9149(03)00105-X

J. Ke-?sik, J. Wro-nski, M. Feldo, P. Terlecki, and T. Zubilewicz, The changes of plasma thrombin-antithrombin complex in the patients with peripheral arterial disease undergoing surgical revascularization, Pol Przegl Chir, vol.85, pp.638-681, 2013.

J. Wang, Y. Wang, and J. Wang, Antithrombin is protective against myocardial ischemia and reperfusion injury, Journal of Thrombosis and Haemostasis, vol.32, issue.6, pp.1020-1028, 2013.
DOI : 10.1111/jth.12243

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702629

H. Tsuboi, Y. Naito, and K. Katada, Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats, AJP: Gastrointestinal and Liver Physiology, vol.292, issue.2, pp.678-83, 2007.
DOI : 10.1152/ajpgi.00361.2006

R. Thuillier, F. Favreau, O. Celhay, L. Macchi, S. Milin et al., Thrombin Inhibition During Kidney Ischemia-Reperfusion Reduces Chronic Graft Inflammation and Tubular Atrophy, Transplantation, vol.90, issue.6, pp.612-633, 2010.
DOI : 10.1097/TP.0b013e3181d72117

S. Bedi, A. Vidyasagar, and A. Djamali, Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis, Transplantation Reviews, vol.22, issue.1, pp.1-5, 2008.
DOI : 10.1016/j.trre.2007.09.004

S. Ma1gorzewicz, E. Skrzypczak-jankun, and J. Jankun, Plasminogen activator inhibitor-1 in kidney pathology (Review), Int J Mol Med, vol.31, pp.503-513, 2013.

C. Granger, J. Miller, and E. Bovill, Rebound Increase in Thrombin Generation and Activity After Cessation of Intravenous Heparin in Patients With Acute Coronary Syndromes, Circulation, vol.91, issue.7, pp.1929-1964, 1995.
DOI : 10.1161/01.CIR.91.7.1929